Nanopore Technologies Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Nanopore Type (Solid-State Nanopore, Biological Nanopore, Hybrid Nanopores), By Application (Clinical research, Assemble genomes, Environmental genomics, Detection of microbes, Others), By End-User (Hospitals & Clinics, Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Nanopore Technologies Market Size

The global nanopore technologies market size was valued at USD 338.04 billion in 2025 and is projected to grow from USD 387.06 billion in 2026 to USD 1143.45 billion by 2034, registering a CAGR of 14.5% during the forecast period from 2026 to 2034. North America dominated the nanopore technologies market with a market share of 39.8% in 2025.

The biopolymers' sequencing, including polynucleotides in the form of DNA or RNA and other components, is done using a third-generation nanopore sequencing technique. Without the requirement for PCR (polymerase chain reaction) amplification or chemical tagging of the sample, single molecule DNA or RNA can be sequenced using nanopore sequencing technology. Additionally, this sequencing can provide substantially less expensive genotyping, increased testing mobility, and rapid sample processing with the capacity to display results in real-time. One of the most recent generations of sequencing technology, which aids in figuring out the nucleotide sequence in DNA or RNA, is used to determine the order of the nucleotides. Utilizing this technology, it is possible to decide on the sequence of a specific nucleic acid by tracking changes in an electric current while a molecule moves through a nanopore.

It is projected that increased innovation and development in nanopore technology would enable employing them to treat new viruses throughout the forecasted time. During the forecasting period, the market for nanopore technologies would benefit from increased DNA sequencing demand for various research applications. The market would also benefit from an increase in the usage of epigenetics to develop newer treatment approaches. Because sequencers can be quickly connected to other technological systems and will make it easier for healthcare professionals to monitor DNA samples in shared cloud computing labs, the introduction of the Internet of Things benefits nanopore technology. It is expected to support market growth over the forecast period.

Product Analysis

The segments include Instruments and Consumables.

The consumables section is projected to advance at a CAGR of 15.1% and hold the largest market share. Nanopore technologies require a variety of consumables, including flow cells, sample preparation kits, sequencing kits, expansion packs, and equipment for DNA and RNA sequencing. Increased demand for consumables has increased the revenue share produced by this segment. Additionally, the industry is expected to rise because of advancements in consumables that make it easier to sequence altered or complex structures. Additionally, various consumables are offered for kits for identifying sequencing, direct cDNA sequencing, field sequencing, 16S barcoding, Cas9 sequencing, and ultra-long DNA sequencing.

The instruments section will hold the second-largest share. Nanopore technologies are carried out using tabletop and portable instruments. The mobility and ease of use of portable devices will undoubtedly benefit from advancements in such fields. Additionally, portable gadgets are made to work with cellphones and other mobile, low-power gadgets. Additionally, cutting-edge equipment is employed for field-based analyses and possible applications like remote pathogen monitoring in an infectious disease outbreak.

Request Customizationto receive a tailored report.

Application Analysis

The segments include DNA sequencing and RNA sequencing.

The DNA sequencing section is projected to advance at a CAGR of 14.81% and hold the largest market share. A, C, G, and T nucleotides in a DNA molecule can be precisely identified via DNA sequencing. The cell's information to form protein and RNA molecules is included in the DNA base sequence. Scientists examining the functioning of genes need to know the DNA sequence. Long DNA fragments can now be directly and instantly analyzed thanks to the novel, scalable nanopore sequencing technology. It functions by watching how electrical current changes as nucleic acids travel through a protein nanopore. The precise DNA sequence is obtained by decoding the resulting signal.

The RNA sequencing section will hold the second-largest share. Using RNA sequencing, it is possible to determine the amount and distribution of RNA in a biological sample. It also examines the constantly evolving transcriptome of the cell. It is known that complex viral transcriptomes can be characterized by using traditional RNA sequencing methods, which are challenging because of high gene density, overlapping reading frames, and complex splicing patterns. Additionally, direct RNA sequencing employing nanopore arrays provides a better alternative since it allows for the direct sequencing of individual polyadenylated RNAs without the recording and amplifying bases in other sequencing technologies.

End-User Insights

The segments include hospitals & clinics, research institutes, and others.

The research institutes section is projected to advance at a CAGR of 14.02% and hold the largest market share. An organization established specifically to conduct research is known as a research institute. Research institutions may occasionally be focused on applied research or specialize in basic research. Numerous research organizations are concentrating on studies to employ nanopore technology for various purposes, including identifying novel viruses that are mutating and forming and are the root cause of numerous diseases. Viral disease incidence has seen a sharp increase, which is expected to increase the need for research institutes to concentrate on creating methods for more effective treatment of such viral diseases.

The other section will hold the second-largest share. Companies in the pharmaceutical and biotechnology industries, academic and governmental institutions, and other similar businesses concentrating on creating cutting-edge nanopore technologies make up the other section. Governmental entities receive funding and investments for advancing technology to continue studying topics connected to medicines and diagnostics.

Speak to an Analystto discuss market opportunities.

Regional Insights

The region-wise segmentation of the global nanopore technologies market share is bifurcated into North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Regional Market

North America will command the market with the largest share while growing at a CAGR of 13.91%. One significant element influencing the growth of the nanopore technology market is the presence of substantial important players in North America, such as Oxford Nanopore Technologies and ONTERA, Inc. Additionally, the rise in viral infections like the coronavirus and the Ebola virus, as well as the availability of cutting-edge healthcare facilities with qualified medical staff, all significantly contribute to the expansion of the North American market. Additionally, the market's growth is mainly related to the rise in demand for improved healthcare services, accompanied by more lavish healthcare spending and technological developments in nanopore technology.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest-Growing Region

Europe will expand at a CAGR of 14.61% and hold USD 195 million. The rapid development of nanopore technologies, the rise in viral disease incidence, and the region's soaring need for new technologies all contribute to expanding nanopore technologies in Europe. The increased demand for healthcare services and the rise in hospitalizations and drug expenses place a significant social strain on European budgets. Hospitals in Europe are spending more money on products and technology due to the increase in viral diseases requiring nanopore technology to identify the virus' DNA. This subsequently fuels the market expansion in this region.

Additionally, the market is expected to develop as more healthcare professionals use nanopore technology to analyze viral genomes. Further, the European market is being driven by new product breakthroughs in nanopore technologies and an increase in the prevalence of viral infections. The presence of established infrastructure in the healthcare sector and the accessibility of qualified personnel are other factors that significantly contribute to the expansion of the Europe nanopore technology market.

List of Key and Emerging Players in Nanopore Technologies Market